2020
DOI: 10.1155/2020/3691701
|View full text |Cite
|
Sign up to set email alerts
|

Mibefradil and Flunarizine, Two T-Type Calcium Channel Inhibitors, Protect Mice against Lipopolysaccharide-Induced Acute Lung Injury

Abstract: Recent studies have illuminated that blocking Ca2+ influx into effector cells is an attractive therapeutic strategy for lung injury. We hypothesize that T-type calcium channel may be a potential therapeutic target for acute lung injury (ALI). In this study, the pharmacological activity of mibefradil (a classical T-type calcium channel inhibitor) was assessed in a mouse model of lipopolysaccharide- (LPS-) induced ALI. In LPS challenged mice, mibefradil (20 and 40 mg/kg) dramatically decreased the total cell num… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…6 B; P <0.01 for pimozide+ZD versus pimozide, unpaired t -test). Additionally, adding T-type Ca 2+ channel blocker mibefradil (Mib; 10 µM) ( Wan et al, 2020 ) into perfusion solution occluded the facilitation effect of ZD7288 on mIPSC frequency ( P >0.05), while perfusing Mib (10 µM) alone had no impact on the frequency of mIPSC ( P >0.05). But facilitation of ZD7288 on mIPSC frequency still exists in the presence of the P/Q-type Ca 2+ channel blocker ω-agatoxin IVA (500 nM), the N-type Ca 2+ channel blocker ω-conotoxin GVIA (500 nM), and the L-type Ca 2+ channel blocker nifedipine ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…6 B; P <0.01 for pimozide+ZD versus pimozide, unpaired t -test). Additionally, adding T-type Ca 2+ channel blocker mibefradil (Mib; 10 µM) ( Wan et al, 2020 ) into perfusion solution occluded the facilitation effect of ZD7288 on mIPSC frequency ( P >0.05), while perfusing Mib (10 µM) alone had no impact on the frequency of mIPSC ( P >0.05). But facilitation of ZD7288 on mIPSC frequency still exists in the presence of the P/Q-type Ca 2+ channel blocker ω-agatoxin IVA (500 nM), the N-type Ca 2+ channel blocker ω-conotoxin GVIA (500 nM), and the L-type Ca 2+ channel blocker nifedipine ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…6B; p <0.01 for pimozide+ZD vs. pimozide, unpaired t -test). Additionally, Adding T-type Ca2+ channel blocker mibefradil (Mib; 10 μM)[44] into perfusion solution occluded the facilitation effect of ZD7288 on mIPSC frequency (p>0.05), while perfusing Mib (10 μM) alone did not affect the frequency of mIPSC (p>0.05). But the facilitation of ZD7288 on mIPSC frequency still exist in the presence of the P/Q-type Ca 2+ channel blocker ω-agatoxin IVA (500 nM), the N-type Ca 2+ channel blocker ω-conotoxin GVIA (500 nM), and the L-type Ca 2+ channel blocker nifedipine (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, there is indirect evidence linking IL-6 and T-channels. T-type inhibitors ameliorate the effects of inflammatory processes related to IL-6 [58,59], and IL-6 regulates T-type channels expression and function [60][61][62].…”
Section: Limitationsmentioning
confidence: 99%